Crackdown On Illegal Drugs And Unlicensed Pharmacies In Dimapur

Shillong:  In a bid to combat illegal drug sales and ensure compliance with health regulations, a team from the department of Health & Family Welfare (H&FW), Drug Control, initiated an intensive inspection of drug licenses and the sale of banned drugs in pharmacies across Dimapur. The drive will also cover Chümoukedima district.

Addressing the media at the District Hospital Dimapur (DHD), Health minister P Paiwang Konyak revealed that illegal drugs, banned by the Indian Council of Medical Research (ICMR), were being sold in some pharmacies. He warned that strict action would be taken against any pharmacy found selling such drugs.

The minister stated that the team would also verify the status of pharmacy licenses, ensuring they were properly renewed and that only qualified pharmacists were operating the establishments. He emphasized that any discrepancies would be addressed, and the ongoing checks would continue in the coming days.

Speaking to Nagaland Post, Deputy Drugs Controller Tiatoshi Amer, who also oversees licensing, explained that the state government had already initiated a crackdown on illegal drugs, in line with the ICMR’s ban on certain categories of medications.

He mentioned that some pharmacies had been found selling banned drugs and that these would be thoroughly inspected. If any such drugs were found, the pharmacy’s license would be revoked.

Additionally, the inspection would focus on pharmacies being run by unauthorized or unqualified individuals. Amer emphasized that the authorities had provided ample time for pharmacies to employ qualified pharmacists, and any failure to comply would result in serious consequences.

Pharmacies operating without valid licenses would be issued a show-cause notice, requiring them to renew their licenses. Failure to comply would lead to license cancellation.

Amer also disclosed that 49 licenses had already been suspended, and if any pharmacies were found to be operating with illegal or invalid documents, the team would recommend the cancellation of their licenses to the government.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16